- Country: Italy
- Summary: Disposal of Patent N.102011901959355 Entitled "Use of a Non-Peptide Antagonist of Prokineticin Receptors for the Therapy of Autoimmune Diseases or an Autoimmune or Disease Component...
- ITT Ref No: 131078193
- Deadline: 13 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Disposal of Patent n.102011901959355 entitled "Use of a non-peptide antagonist of prokineticin receptors for the therapy of autoimmune diseases or an autoimmune component or of dysimmune diseases or with a dysimmune component
- Documents:
Delibera-CDA-n.-82-del-27-novembre-2025_Dismissione-Brevetto-n.102011901959355.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDisposal of Patent N.102011901959355 Entitled "Use of a Non-Peptide Antagonist of Prokineticin Receptors for the Therapy of Autoimmune Diseases or an Autoimmune or Disease Component... - Italy Tender
The IRCCS CARLO BESTA NEUROLOGICAL INSTITUTE, a Government sector organization in Italy, has announced a new tender for Disposal of Patent N.102011901959355 Entitled "Use of a Non-Peptide Antagonist of Prokineticin Receptors for the Therapy of Autoimmune Diseases or an Autoimmune or Disease Component.... This tender is published on ItalyTenders under ITT Ref No: 131078193 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-13.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
